NCT07062770View on ClinicalTrials.gov

Assessment of Circuit Rebreathing During CPAP Therapy

NARecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Obstructive Sleep Apnea (OSA)
Interventions
DEVICE

Continuous positive airway pressure (CPAP)

Subjects will be administered either 0, 5 or 10 cmH2O

OTHER

Mask exhaust port flow

Subjects will be administered varying levels of exhaust flow: 35, 23, 18, 13 and 8 L/s

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Sleep Res, Inc.

UNKNOWN

lead

Brigham and Women's Hospital

OTHER

NCT07062770 - Assessment of Circuit Rebreathing During CPAP Therapy | Biotech Hunter | Biotech Hunter